Grants and Contributions:
Title:
DNA Vaccine Platform Development
Agreement Number:
988568
Agreement Value:
$49,992.00
Agreement Date:
Apr 1, 2022 - Mar 15, 2023
Description:
Pegasus Biotech is developing a DNA vaccine development platform to provide accelerated vaccine development services to new and existing clients.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1A 4P3
Reference Number:
172-2022-2023-Q1-988568
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
760829879
Recipient Type:
For-profit organization
Recipient's Legal Name:
Pegasus Biotech Incorporated
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710